ArticleSubstance abuse2023

Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act.

Brendan Saloner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.